Author Bauer, Chris
-
2013 | Journal Article | Research Paper
Analysis of amino-terminal variants of amyloid-β peptides by capillary isoelectric focusing immunoassay
Haußmann, U.; Jahn, O. ; Linning, P.; Janßen, C.; Liepold, T.; Portelius, E. & Zetterberg, H. et al. (2013)
Analytical Chemistry, 85(17) pp. 8142-8149. DOI: https://doi.org/10.1021/ac401055y
Details DOI PMID PMC
-
2016 | Journal Article
Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort
Klafki, H.-W. ; Hafermann, H.; Bauer, C.; Haußmann, U.; Kraus, I. ; Schuchhardt, J. & Muck, S. et al. (2016)
Journal of Alzheimer's Disease, 54(2) pp. 691-705. DOI: https://doi.org/10.3233/jad-160398
Details DOI
-
2017 | Journal Article |
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
Frölich, L.; Peters, O.; Lewczuk, P. ; Gruber, O. ; Teipel, S. J.; Gertz, H. J. & Jahn, H. et al. (2017)
Alzheimer's Research & Therapy, 9(1) art. 84. DOI: https://doi.org/10.1186/s13195-017-0301-7
Details DOI
-
2018 | Journal Article |
A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease
Shahpasand-Kroner, H.; Klafki, H.-W.; Bauer, C.; Schuchhardt, J.; Hüttenrauch, M.; Stazi, M. & Bouter, C. et al. (2018)
Alzheimer's Research & Therapy, 10(1) art. 121. DOI: https://doi.org/10.1186/s13195-018-0448-x
Details DOI
-
2019 | Journal Article
Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer’s disease
Santos, J. R. F.; Bauer, C.; Schuchhardt, J.; Wedekind, D. ; Waniek, K.; Lachmann, I. & Wiltfang, J. et al. (2019)
Journal of Neural Transmission, 126(3) pp. 339-348. DOI: https://doi.org/10.1007/s00702-019-01982-5
Details DOI
-
2020 | Journal Article
Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer’s Disease Dementia via Lead-Lag Analysis
Fuentes, M.; Klostermann, A.; Kleineidam, L.; Bauer, C.; Schuchhardt, J.; Maier, W. & Jessen, F. et al. (2020)
Journal of Alzheimer's Disease, 76(3) pp. 1005-1015. DOI: https://doi.org/10.3233/JAD-200230
Details DOI
-
2022 | Journal Article |
Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network
Benson, G. S.; Bauer, C.; Hausner, L.; Couturier, S.; Lewczuk, P.; Peters, O. & Hüll, M. et al. (2022)
Journal of Neural Transmission,. DOI: https://doi.org/10.1007/s00702-022-02461-0
Details DOI
-
2022 | Journal Article | Research Paper |
Diagnostic performance of automated plasma amyloid-β assays combined with pre-analytical immunoprecipitation
Klafki, H.-W. ; Vogelgsang, J.; Manuilova, E.; Bauer, C.; Jethwa, A.; Esselmann, H. & Jahn-Brodmann, A. et al. (2022)
Alzheimer's Research & Therapy, 14(1) art. 127. DOI: https://doi.org/10.1186/s13195-022-01071-y
Details DOI
-
2022 | Journal Article |
Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
Klafki, H.-W.; Morgado, B.; Wirths, O.; Jahn, O.; Bauer, C.; Esselmann, H. & Schuchhardt, J. et al. (2022)
Fluids and Barriers of the CNS, 19(1) art. 96. DOI: https://doi.org/10.1186/s12987-022-00390-4
Details DOI
-
2024 | Journal Article
Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease
Morgado, B.; Klafki, H.-W.; Bauer, C.; Waniek, K.; Esselmann, H.; Wirths, O. & Hansen, N. et al. (2024)
European Archives of Psychiatry and Clinical Neuroscience,. DOI: https://doi.org/10.1007/s00406-023-01751-2
Details DOI